News Preview
Forget Treasury Bonds: This 6%-Yielding Pharma Stock Pays You to Wait for Its Pipeline
A pharmaceutical company with a reliable dividend and growing cancer treatment pipeline is an attractive investment option, given its improving guidance.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.